FR941017-2-00051 FR941017-2-00034 [Docket No. 94N&hyph;0287] Glaxo, Inc., et al.; Withdrawal of Approval of 13 Abbreviated Antibiotic Applications and 2 Abbreviated New Drug Applications; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of August 4, 1994 (59 FR 39773). The document withdrew approval of 13 abbreviated antibiotic applications (AADA's) and 2 abbreviated new drug applications (ANDA's). The document was published with a typographical error. This document corrects that error. FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy (HF&hyph;27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;2994. SUPPLEMENTARY INFORMATION: In FR Doc. 94&hyph;18971 appearing on page 39773 in the Federal Register of Thursday, August 4, 1994, the following correction is made: On page 39773, in the first column of the table, the application no. ``AADA 629&hyph;053'' is corrected to read ``AADA 62&hyph;053''. Dated: October 5, 1994. Janet Woodcock, Director, Center for Drug Evaluation and Research. [FR Doc. 94&hyph;25636 Filed 10&hyph;14&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
